U. S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 8-K
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
Date of Report: November 4, 1997
Commission file number 0-19866
CELOX LABORATORIES, INC.
------------------------
(Exact name of small business issuer as
specified in its charter)
MINNESOTA 36-3384240
--------- ----------
(State or other jurisdiction (I.R.S. Employer
of incorporation or organization) Identification Number)
1311 HELMO AVENUE, OAKDALE, MINNESOTA 55128
- ---------------------------------------- -----
(Address of principal executive offices) (Zip code)
Issuers telephone number, including area code: (612) 730-1500
Item 5. Other Events-Resignations from the Board of Directors
During the last week of October, 1997 the Chairman of the Board of
Directors requested and received resignations from the Company's three outside
directors. These resignations had been requested by the Chairman based upon the
strategic focus of the Company and the need for expertise in the bio medical
field. As a result, the Company does not have any outside directors. The Company
intends to identify and interview qualified candidates for the open director
positions as soon as practical.
SIGNATURE
---------
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Celox Laboratories, Inc.
November 4, 1997 By /s/ Milo R. Polovina
Milo R. Polovina, Chairman
